A detailed history of Lion Street Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Lion Street Advisors, LLC holds 5,877 shares of ABBV stock, worth $1 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
5,877
Previous 5,868 0.15%
Holding current value
$1 Million
Previous $1.01 Million 15.31%
% of portfolio
0.41%
Previous 0.38%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$163.84 - $199.33 $1,474 - $1,793
9 Added 0.15%
5,877 $1.16 Million
Q2 2024

Jul 12, 2024

SELL
$154.79 - $180.76 $9,596 - $11,207
-62 Reduced 1.05%
5,868 $1.01 Million
Q4 2023

Jan 09, 2024

SELL
$137.6 - $154.97 $688,963 - $775,934
-5,007 Reduced 45.78%
5,930 $918,000
Q3 2023

Oct 19, 2023

BUY
$133.59 - $154.65 $507,374 - $587,360
3,798 Added 53.2%
10,937 $1.63 Million
Q2 2023

Jul 28, 2023

SELL
$132.51 - $164.9 $420,321 - $523,062
-3,172 Reduced 30.76%
7,139 $961,000
Q1 2023

Apr 12, 2023

BUY
$144.61 - $166.54 $802,151 - $923,797
5,547 Added 116.44%
10,311 $1.64 Million
Q4 2022

Jan 19, 2023

SELL
$138.31 - $165.87 $503,310 - $603,600
-3,639 Reduced 43.31%
4,764 $0
Q3 2022

Oct 18, 2022

BUY
$134.21 - $153.93 $488,390 - $560,151
3,639 Added 76.39%
8,403 $1.13 Million
Q2 2022

Jul 19, 2022

BUY
$137.62 - $174.96 $7,293 - $9,272
53 Added 1.13%
4,764 $542,000
Q1 2022

May 10, 2022

SELL
$131.98 - $163.75 $6,598 - $8,187
-50 Reduced 1.05%
4,711 $760,000
Q4 2021

Jan 20, 2022

SELL
$107.43 - $135.93 $52,640 - $66,605
-490 Reduced 9.33%
4,761 $648,000
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $558,706 - $634,215
5,251 New
5,251 $567,000
Q2 2020

Jul 20, 2020

SELL
$73.37 - $98.18 $27,953 - $37,406
-381 Closed
0 $0
Q1 2020

May 06, 2020

BUY
$64.5 - $97.79 $24,574 - $37,257
381 New
381 $29,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Lion Street Advisors, LLC Portfolio

Follow Lion Street Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lion Street Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lion Street Advisors, LLC with notifications on news.